| A large number of pharmaceutical and | | | | only in the actual production of the pharmaceutical |
| biotechnology companies are now outsourcing | | | | product, there are companies that provide |
| their drug development requirements to | | | | comprehensive services, taking over product |
| independent pharmaceutical development | | | | development right from the earliest stage of |
| companies. The reason behind this lies in the fact | | | | chemical discovery and experimentation and up to |
| that the development of synthetic medication | | | | the evaluation of the effects of the finished |
| entails a highly specialized, not to mention costly, | | | | product. |
| process. Companies can save a lot of money, and | | | | Pharmaceutical and biotechnology companies can |
| ensure the quality of their products by passing | | | | greatly benefit from employing the services of an |
| their technical product formulation processes to | | | | independent pharmaceutical development |
| expert and experienced pharmaceutical | | | | company. By outsourcing their technical processes |
| companies. | | | | to these professional firms, the companies can |
| Independent pharmaceutical product development | | | | focus more on the entrepreneurial and marketing |
| firms are more likely to have an established | | | | side of their business. |
| technical grasp of the field of drug formulation and | | | | Since they would not need to spend too much on |
| development. They will also have adequate | | | | advanced drug development equipment and |
| experimentation and production tools and | | | | laboratories, the company can allocate its budget |
| facilitates as the employ a team of highly | | | | toward more pressing issues. The company will |
| competent and experienced scientists and | | | | also be able to keep up with the fast paced |
| professional pharmacists. While some drug | | | | pharmaceutical and biotechnology industry with |
| development companies assist their partner firms | | | | minimized difficulty. |